טוען...
Renovascular hypertension from the BCR‐ABL tyrosine kinase inhibitor ponatinib
Drug‐induced hypertension is one of the commonest causes of secondary hypertension. In the last few years, secondary hypertension due to tyrosine kinase inhibitors, from the vascular endothelial growth factor class, has been recognized to be an important cause of hypertension, as well as proteinuria...
שמור ב:
| הוצא לאור ב: | J Clin Hypertens (Greenwich) |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8029973/ https://ncbi.nlm.nih.gov/pubmed/32175644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13843 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|